Brian M. Fox
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 10%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Catalytic C–H Functionalization Methods
- Synthesis and Catalytic Reactions
Papers in
-
- Cancer therapeutics and mechanisms 4
- Synthesis and bioactivity of alkaloids 3
- Peroxisome Proliferator-Activated Receptors 1
- Phenothiazines and Benzothiazines Synthesis and Activities 1
- Ubiquitin and proteasome pathways 1
-
- Click Chemistry and Applications 1
- Co-authors
- Mark Cushman (5 shared papers)Yves Pommier (4 shared papers)Glenda Kohlhagen (3 shared papers)Muthusamy Jayaraman (3 shared papers)Jeffrey A. Vroman (2 shared papers)Dirk Strumberg (1 shared paper)Melinda G. Hollingshead (2 shared papers)Smitha Antony (2 shared papers)
- Journals
- Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Brian M. Fox
10 papers receiving 521 citations
Peers
Comparison fields: 5 of 54
- Toxicology 116
- Organic Chemistry 279
- Cancer Research 74
- Molecular Biology 314
- Pharmacology 56
Countries citing papers authored by Brian M. Fox
This map shows the geographic impact of Brian M. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian M. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian M. Fox more than expected).
Fields of papers citing papers by Brian M. Fox
This network shows the impact of papers produced by Brian M. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian M. Fox. The network helps show where Brian M. Fox may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian M. Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 150 | |
| 2 | 2001 | 88 | |
| 3 | 2003 | 86 | |
| 4 | 2015 | 54 | |
| 5 | 2001 | 34 | |
| 6 | 2009 | 33 | |
| 7 | 2010 | 31 | |
| 8 | 2010 | 24 | |
| 9 | 2006 | 15 | |
| 10 | 2011 | 13 |
About Brian M. Fox
Brian M. Fox is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Toxicology and Biochemistry, having authored 10 papers that have together received 528 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Synthesis and bioactivity of alkaloids (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Phenothiazines and Benzothiazines Synthesis and Activities (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper), Ubiquitin and proteasome pathways (1 paper) and Click Chemistry and Applications (1 paper). The work is most often cited by research in Toxicology (116 citations), Organic Chemistry (279 citations), Cancer Research (74 citations), Molecular Biology (314 citations) and Pharmacology (56 citations). Brian M. Fox has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Mark Cushman, Yves Pommier, Glenda Kohlhagen, Muthusamy Jayaraman, Jeffrey A. Vroman, Dirk Strumberg, Melinda G. Hollingshead, Smitha Antony, Lance Stewart and Bart L. Staker. Their work appears in journals such as Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.